September 27, 2016 1:02 AM ET

Life Sciences Tools and Services

Company Overview of ChemDiv, Inc.

Company Overview

ChemDiv, Inc. operates as a discovery and development contract research organization in the United States and internationally. The company executes pre-clinical chemistry and biology for drug development and clinical trials for an international portfolio of companies across the range of targets with small molecule and biotech drugs. It specializes in early and clinical development of anti-infectives and antivirals, oncologics, CNS, cardiometabolics, and anti-inflammatory therapies. The company’s services include synthetic chemistry, structural biology and structure-based drug discovery, molecular modeling, medicinal chemistry, scale-up, biochemical and cellular assay development, analytical/...

6605 Nancy Ridge Drive

San Diego, CA 92121

United States

Founded in 1990

Phone:

858-794-4860

Fax:

858-794-4931

Key Executives for ChemDiv, Inc.

Chief Executive Officer
Founder, Chief Scientific Officer and Member of the Scientific Advisory Board
Chief Technology Officer and Vice President of Biology
Senior Vice President of Corporate Development and General Manager
Compensation as of Fiscal Year 2016.

ChemDiv, Inc. Key Developments

ChemDiv, Inc. and Insilico Medicine, Inc. Form a Strategic Alliance to Develop Oncology Focused Libraries Using Artificial Intelligence

ChemDiv, Inc. and Insilico Medicine, Inc. announced the signing of a collaboration agreement aimed at partnering to develop and market annotated compound libraries targeting various types of cancer. These innovative libraries will advance the discovery of new oncology drug candidates. Insilico Medicine’s pharmaceutical artificial intelligence platform based on expertise in ‘omics’ data analysis and deep learning methods will add a valuable annotated component to ChemDiv’s anticancer library, and, combined with ChemDiv’s proprietary chemistry focused on small molecule drug development, will provide several thousand new oncology candidates. The first product line will contain the libraries of novel compounds against 18 types of cancer, including bladder urothelial carcinoma, breast invasive carcinoma, endocervical adenocarcinoma, colon and rectal cancer, kidney renal papillary cell carcinoma, lung adenocarcinoma, prostate adenocarcinoma, sarcoma.

ChemDiv Announces New Drug Discovery Collaboration Agreement with Cystic Fibrosis Foundation Therapeutics, Inc

ChemDiv announced that it has entered into a new drug discovery collaboration agreement with Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT). The agreement enables CFFT to use ChemDiv's unique chemistry platform to advance promising scientific research in the field of cystic fibrosis (CF) treatment. This collaboration allows ChemDiv to assist the CF clinical trials network in the world and contribute to the development of a lifelong cure for cystic fibrosis. According to the agreement, ChemDiv will provide discovery chemistry services to CFFT for their innovative research programs aimed at the development of lifesaving new therapies for cystic fibrosis.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact ChemDiv, Inc., please visit www.chemdiv.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.